Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
18.15
+0.15 (0.83%)
At close: Jun 26, 2026, 4:00 PM EDT
18.39
+0.24 (1.32%)
After-hours: Jun 26, 2026, 7:27 PM EDT
Trevi Therapeutics Employees
Trevi Therapeutics had 34 employees as of December 31, 2025. The number of employees increased by 8 or 30.77% compared to the previous year.
Employees
34
Change (1Y)
8
Growth (1Y)
30.77%
Revenue / Employee
n/a
Profits / Employee
-$1,341,500
Market Cap
2.58B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vericel | 398 |
| Intellia Therapeutics | 377 |
| Tarsus Pharmaceuticals | 370 |
| Nurix Therapeutics | 317 |
| Biohaven | 274 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 154 |
| Pharvaris | 134 |
TRVI News
- 10 days ago - Trevi Therapeutics Announces Upcoming June and July Event Schedule - GlobeNewsWire
- 24 days ago - Trevi Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Trevi Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Trevi Therapeutics price target raised to $30 from $18 at Stifel - TheFly
- 7 weeks ago - Trevi Therapeutics price target raised to $29 from $21 at Clear Street - TheFly
- 7 weeks ago - Trevi Therapeutics Transcript: Investor Day 2026 - Transcripts
- 7 weeks ago - Trevi Therapeutics Slides: FY 2026 - Filings
- 7 weeks ago - Trevi Therapeutics price target raised to $20 from $18 at Morgan Stanley - TheFly